Talkspace (TALK) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
6 Aug, 2026Executive summary
Revenue for Q2 2026 was $61.7M, up 13.6% year-over-year, driven by a 27.1% increase in Payor revenue, offset by declines in DTE and Consumer segments.
Net loss for Q2 2026 was $1.5M, compared to $0.5M in Q2 2025; net loss for the first half of 2026 was $7.8M, up from $0.2M in the prior year period.
A definitive merger agreement was signed with Universal Health Services, Inc. (UHS) for $5.25 per share in cash, valuing the transaction at $835M and expected to close in Q3 2026.
Transaction-related costs for the merger totaled $0.9M in Q2 and $8.2M for the first half of 2026.
Financial highlights
Q2 2026 revenue: $61.7M (+13.6% YoY); H1 2026 revenue: $123.4M (+15.8% YoY).
Q2 2026 net loss: $1.5M; H1 2026 net loss: $7.8M.
Adjusted EBITDA for Q2 2026 was $1.0M, compared to $2.3M in Q2 2025; H1 2026 adjusted EBITDA was $7.1M, up from $4.2M in H1 2025.
Cash, cash equivalents, and marketable securities totaled $91.0M as of June 30, 2026; no debt outstanding.
Outlook and guidance
The merger with UHS is expected to close in Q3 2026, after which the company will be delisted from NASDAQ.
Management anticipates sufficient liquidity for at least the next 12 months and the foreseeable future.
Latest events from Talkspace
- Revenue up 18%, net loss from merger costs, UHS acquisition expected Q3 2026.TALK
Q1 2026 - Board unanimously recommends approval of $5.25/share cash merger with UHS; key holders support.TALK
Proxy filing - Stockholders to vote on $5.25/share cash merger with UHS, with board unanimous support and fairness opinion.TALK
Proxy filing - Definitive agreement for acquisition by UHS to create a national behavioral health continuum.TALK
Proxy Filing - Shareholders to receive $5.25 per share in all-cash merger, pending approvals and clearances.TALK
Proxy Filing - UHS to acquire Talkspace for $835M, expanding virtual behavioral health services nationwide.TALK
Proxy Filing - Q3 2025 saw 25% revenue growth, 111% higher adjusted EBITDA, and raised full-year guidance.TALK
Q3 2025 - Q3 revenue up 23% YoY, net income positive, and Payor segment drives growth and expansion.TALK
Q3 2024 - Q1 2025 revenue up 15% year-over-year, Payor segment drove growth, net income positive.TALK
Q1 2025